Answers are grounded in this paper and cite their sources.
Malignant tumours of the brain and brain stem compel an attitude of critical optimism on the part of the neurosurgeon and the radiation therapist in their approach to the problems both of the attack upon the individual tumour and the assessment of the results in the several types of neoplasm. The constantly painstaking, sometimes bold, progress of neurosurgery over the last two decades is well known. The drama of surgery is enhanced, in this field, by the close proximity of vital structures, the often critical state of the patient, and the urgent need to avoid further damage to function. The forte of radiation therapy is more humdrum, save possibly in the medulloblastomas, and not without some disappointment and headache. But if, ultimately, it is to be found valuable in the control of extension or recurrence of brain neoplasms (which the surgeon rarely can remove in toto), a consistent pattern or method of treatment must be used intelligently in a fairly large series of cases, and then critically surveyed. This may take some years, and optimism may encounter a few set-backs. Because of the nature and location of these malignant tumours, the obscurity of symptoms and delayed clinical recognition, there will be a fairly high loss within relatively few months regardless of the means of treatment. This is further accentuated by the fact that about one-third of all these neoplasms are the most rapidly growing and malignant of the gliomas, the glioblastoma multiforme. A number of them arise in surgically inaccessible regions, so that even local decompression by aspiration of a portion of the tumour is dangerous to life. Some will endanger life by obstruction to the cerebrospinal fluid pathway, and may not be amenable to Torkildsen's ventriculo-subarachnoid cannulization nor the more recently suggested ventriculo-peritoneal intubation. During the ten-year period from Jan. 1, 1939, to Dec. 31, 1948, 243 patients with malignant tumours of the brain and stem, 13 with meningeal fibroblastomas, and 32 with pituitary adenomas have been referred from the Neurosurgical Service of the Royal Victoria Hospital and Montreal Neurological Institute, and accepted for radiation therapy. The pattern of treatment, especially of the gliomas of the brain and stem, has been maintained consistently, and the analysis of the results will show some revision of our previous report (1944) upon the first five years of the period. For 46 patients in the series, treated prior to January 1948, follow-up records are incomplete at this time (18.1 per cent). Thirty patients treated in 1948 are grouped with the incompletely followed inasmuch as their survival periods had not yet extended beyond the average postoperative survival observed by Penfield, Elvidge, and Cone (1935). Only brief comment will be made upon the medulloblastomas (32 cases), concerning which we have recently published a report.
No takes yet. Share an insight, caveat, or question.
Peirce et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: